Amyloid imaging in Alzheimer's disease: comparison of florbetapir and Pittsburgh compound-B positron emission tomography.

Amyloid imaging in Alzheimer's disease: comparison of florbetapir and Pittsburgh compound-B positron emission tomography.
复制标题

DOI:
10.1136/jnnp-2012-302548
复制
发表时间:
2012-09
期刊:
Journal of neurology, neurosurgery, and psychiatry
影响因子:
--
通讯作者:
Arnold SE
Arnold SE
中科院分区:
其他
文献类型:
--
作者:
Wolk DA;Zhang Z;Boudhar S;Clark CM;Pontecorvo MJ;Arnold SE

文献摘要

参考文献

被引文献

相似文献

淀粉样蛋白成像提供阿尔茨海默病(AD)的纤维状淀粉样蛋白-β(Aβ)斑块的体内检测。PET配体匹兹堡化合物-B(PiB-C11)是研究最充分的淀粉样蛋白成像剂,但碳-11的短半衰期限制了其临床可行性。Florbetapir-F18最近证实了与死后Aβ组织病理学的体内相关性,但尚未与PiB-C11进行直接比较。14名认知正常的成年人和12名AD患者在28天内接受了PiB-C11和florbetapir-F18 PET扫描。两种配体均显示出高度显著的组区分和区域摄取相关性,支持了florbetapir-F18提供了与PiB-C11相当的信息的假设。
Amyloid imaging provides in vivo detection of the fibrillar amyloid-β (Aβ) plaques of Alzheimer's Disease (AD). The PET ligand Pittsburgh Compound-B (PiB-C11) is the most well studied amyloid imaging agent, but the short half-life of carbon-11 limits its clinical viability. Florbetapir-F18 recently demonstrated in vivo correlation with post-mortem Aβ histopathology, but has not been directly compared with PiB-C11. Fourteen cognitively normal adults and 12 AD patients underwent PiB-C11 and florbetapir-F18 PET scans within a 28 day period. Both ligands displayed highly significant group discrimination and correlation of regional uptake, supporting the hypothesis that florbetapir-F18 provides comparable information with PiB-C11.
DOI: 10.1016/s1474-4422(08)70001-2
发表时间: 2008-02-01
期刊: LANCET NEUROLOGY
影响因子: 48
作者:
Rowe, Christopher C.;Ackerman, Uwe;Villemagne, Victor L.
通讯作者: Villemagne, Victor L.
DOI: 10.1002/ana.20009
发表时间: 2004-03-01
影响因子: 11.2
作者:
Klunk, WE;Engler, H;Långström, B
通讯作者: Långström, B
DOI: 10.1001/jama.2010.2008
发表时间: 2011-01-19
期刊: JAMA
影响因子: --
作者:
Clark CM;Schneider JA;Bedell BJ;Beach TG;Bilker WB;Mintun MA;Pontecorvo MJ;Hefti F;Carpenter AP;Flitter ML;Krautkramer MJ;Kung HF;Coleman RE;Doraiswamy PM;Fleisher AS;Sabbagh MN;Sadowsky CH;Reiman EP;Zehntner SP;Skovronsky DM;AV45-A07 Study Group
通讯作者: AV45-A07 Study Group
DOI: 10.1001/archneurol.2011.153
发表时间: 2011-11
影响因子: --
作者:
Wolk DA;Grachev ID;Buckley C;Kazi H;Grady MS;Trojanowski JQ;Hamilton RH;Sherwin P;McLain R;Arnold SE
通讯作者: Arnold SE
DOI: 10.1212/wnl.0b013e3181c7da8e
发表时间: 2010-01-05
期刊: NEUROLOGY
影响因子: 9.9
作者:
Burack, M. A.;Hartlein, J.;Cairns, N. J.
通讯作者: Cairns, N. J.